Independent COL5A1 Variants in Cats with Ehlers-Danlos Syndrome

Genes (Basel). 2022 Apr 29;13(5):797. doi: 10.3390/genes13050797.

Abstract

We investigated four cats with similar clinical skin-related signs strongly suggestive of Ehlers-Danlos syndrome (EDS). Cases no. 1 and 4 were unrelated and the remaining two cases, no. 2 and 3, were reportedly siblings. Histopathological changes were characterized by severely altered dermal collagen fibers. Transmission electron microscopy in one case demonstrated abnormalities in the collagen fibril organization and structure. The genomes of the two unrelated affected cats and one of the affected siblings were sequenced and individually compared to 54 feline control genomes. We searched for private protein changing variants in known human EDS candidate genes and identified three independent heterozygous COL5A1 variants. COL5A1 is a well-characterized candidate gene for classical EDS. It encodes the proα1 chain of type V collagen, which is needed for correct collagen fibril formation and the integrity of the skin. The identified variants in COL5A1 are c.112_118+15del or r.spl?, c.3514A>T or p.(Lys1172*), and c.3066del or p.(Gly1023Valfs*50) for cases no. 1, 2&3, and 4, respectively. They presumably all lead to nonsense-mediated mRNA decay, which results in haploinsufficiency of COL5A1 and causes the alterations of the connective tissue. The whole genome sequencing approach used in this study enables a refinement of the diagnosis for the affected cats as classical EDS. It further illustrates the potential of such experiments as a precision medicine approach in animals with inherited diseases.

Keywords: Felis catus; animal model; dermatology; genodermatosis; precision medicine; skin.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Cats / genetics
  • Collagen / genetics
  • Collagen Type V / genetics
  • Ehlers-Danlos Syndrome* / genetics
  • Ehlers-Danlos Syndrome* / veterinary
  • Exons

Substances

  • Collagen Type V
  • Collagen

Supplementary concepts

  • Ehlers-Danlos syndrome type 1

Grants and funding

This research was funded by the Swiss National Science Foundation, grant number 310030_200354.